Mortality, cardiovascular events and risk factors in hypopituitarism

Growth Hormone and IGF Research

Volumn 8, Issue SUPPL. 1, 1998, Pages 69-76

  Clayton, R N ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEART DEATH; HORMONE DEFICIENCY; HUMAN; HYPERTENSION; HYPOGONADISM; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032454040     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1096-6374(98)80013-0     Document Type: Article

References (4)

1. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-288.
2. Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrin Metab 1996; 81: 1169-1172.
3. Bülow B, Hagmar L, Mikoczy Z, Nordström CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997; 46: 75-81.
4. Bates AS, Bullivant B, Clayton RN, Sheppard MC, Stewart PM. Increased mortality in hypopituitarism is not due to an increase in vascular mortality. J Endocrinol 1997; 152(Suppl.): OC9.